Research Radboudumc Technology Centers Radboud Biobank News Biobank Preparation and storage of tissue samples – Radboud Biobank

28 August 2018

Official United States Air Force Website The Pathology department prepares and stores tissue from Radboudumc patients on a large scale. This is carried out in a uniform and well documented manner.

Some of the tissue is stored in the Pathology department’s diagnostic archive and some is stored in the Radboud Biobank. The diagram demonstrates how the tissue is sub-divided and further explanation is given below.

1. Opt-out

Left-over tissue in the Pathology Department’s diagnostic archive – from patients who have not signed an informed consent and:
Have not objected to further use of their tissue for research and education purposes via mijnRadboud.
OR
Have objected to further use of their tissue for research and education purposes  (this tissue remains available for diagnostic purposes only).
 
Both resection material and biopsies in this category are stored in the Pathology department’s diagnostic archive.  
 

2. Opt-in

Left-over tissue for the Radboud Biobank – from patients who have signed an informed consent for one of the sub-biobanks accommodated by the Radboud Biobank.
 
Resection tissue comes from the clinical setting via the central reception of the tissue preparation area  and is eventually stored at the Radboud Biobank. In general 4 tissue blocks are stored  (2x unaffected tissue, fresh frozen and paraffin embedded) plus  2x affected tissue samples, fresh frozen and paraffin embedded). The blocks are approximately  0,5 cm3. If desired it is possible to store more blocks depending on the size of the resected tissue. The maximum number of blocks is 16 (4x fresh frozen unaffected, 4x paraffin embedded unaffected, 4x fresh frozen affected, 4x paraffin embedded affected).
 
Biopsies are handled by the Pathology department according to the secondary use protocol, i.e. the tissue is prepared in the routine manner.  Should (a part of) a biopsy be desired for research purposes and before the research proposal is presented to the CMO-light,  the Radboud Biobank will check if there is enough tissue for the issuance and if both the sub-biobank and the pathologist concerned agree to the issuance.
 
N.B. Taking extra biopsies for a sub-biobank initiative is not permitted. A concrete research proposal with a specific informed consent that must be reviewed by the Radboudumc CMO commission  is required for an extra biopsy (i.e. this research falls under the Dutch WMO legislation).
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


Farewell Dorine Swinkels

1 September 2026

On Friday, September 4th, 2026, Dorine Swinkels will retire as Professor of Experimental Clinical Chemistry at Radboudumc. She is also leaving the Radboud Biobank.

go to page

Greening Radboud Biobank – reduction number of aliquots in storage for future initiatives

1 September 2026

Like LUMC and NKI, the Radboud Biobank will also store fewer aliquots per collection tube.

go to page

Effect of Fit & Funding on external invoices

1 September 2026

The Radboud Biobank not only manages issuances and projects for Radboudumc but also provides external services. The Radboud Biobank invoices the external organization for these services.

go to page

New link between iLES and Castor EDC connects clinical data and biobank material

1 September 2026

The Biobank Information Management System, iLES, is now linked to Castor EDC. This development was realized within a KWF-funded project.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page